Geroprotective effects of diet and exercise plus metformin in frail older veterans with obesity: The DEMFOS randomized trial protocol.

Nina Klonis, Maria Liza Duremdes Nava, Marlene Aguilar, Viola Viola, Vincent Davila, Salina Teo, Mon S Bryant, Reina Armamento-Villareal, Clifford Qualls, Dennis T Villareal

Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey VA Medical Center, Houston, TX, USA; Division of Endocrinology, Diabetes, and Metabolism, Baylor College of Medicine, Houston, TX, USA. · pubmed

Paper

Abstract

Frailty and obesity frequently coexist in older adults, particularly among Veterans, contributing to loss of independence, physical disability, and increased healthcare utilization. Lifestyle interventions improve mobility and function but often lead to loss of lean mass and bone density. Metformin, a widely used antidiabetic agent with geroprotective properties, may mitigate these adverse effects by targeting cellular mechanisms of aging.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims that combining diet and exercise with metformin can improve health outcomes in frail older veterans with obesity. This research is relevant as it explores interventions that may address underlying mechanisms of aging and frailty, rather than merely treating symptoms.

Author of this paper? Send a correction.